Interleukin-12 human recombinant

DB19299InvestigationalProtein Based Therapies

Interleukin-12 human recombinant: Overview.

Mechanism: Pharmacologically active on Interleukin-12 receptor subunit beta-1 and Interleukin-12 receptor subunit beta-2
Curator reviewed
Also known as: Human interleukin 12 recombinant · Human interleukin-12 recombinant · Recombinant human interleukin 12
Code names: NM-IL 12 · RH-IL-12

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Interleukin-12 human recombinant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.